Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 3
1948 2
1949 1
1950 2
1951 3
1952 2
1953 1
1954 1
1956 2
1957 2
1958 1
1959 2
1960 2
1961 1
1962 3
1963 6
1964 7
1965 4
1967 1
1969 1
1970 2
1972 1
1975 1
1976 2
1977 6
1979 5
1980 4
1981 5
1982 2
1983 6
1984 6
1985 9
1986 29
1987 64
1988 365
1989 706
1990 763
1991 748
1992 790
1993 784
1994 781
1995 737
1996 743
1997 761
1998 734
1999 723
2000 744
2001 740
2002 781
2003 850
2004 849
2005 951
2006 933
2007 979
2008 1083
2009 1209
2010 1315
2011 1469
2012 1488
2013 1494
2014 1622
2015 1591
2016 1613
2017 1638
2018 1621
2019 1625
2020 1256
2021 54
Text availability
Article attribute
Article type
Publication date

Search Results

31,699 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Treatment and biology of pediatric acute lymphoblastic leukemia.
Kato M, Manabe A. Kato M, et al. Pediatr Int. 2018 Jan;60(1):4-12. doi: 10.1111/ped.13457. Pediatr Int. 2018. PMID: 29143423 Review.
Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy. ...Treatment for pediatric ALL typically consists of induction therapy with steroids, vincristine, and asparaginase with or without anthracycline, followed
Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy. ...Treatment for pediatric
Advances in adult acute lymphoblastic leukemia therapy.
Aldoss I, Stein AS. Aldoss I, et al. Leuk Lymphoma. 2018 May;59(5):1033-1050. doi: 10.1080/10428194.2017.1354372. Epub 2017 Jul 26. Leuk Lymphoma. 2018. PMID: 28745565 Review.
Progress in adult acute lymphoblastic leukemia (ALL) treatment has been met with challenge until recently. ...In this review, we will discuss the most significant advances in treating adult ALL observed in the last five years that have the potential to …
Progress in adult acute lymphoblastic leukemia (ALL) treatment has been met with challenge until recently. ...In …
Immunotherapy in pediatric acute lymphoblastic leukemia.
Inaba H, Pui CH. Inaba H, et al. Cancer Metastasis Rev. 2019 Dec;38(4):595-610. doi: 10.1007/s10555-019-09834-0. Cancer Metastasis Rev. 2019. PMID: 31811553 Free PMC article. Review.
The 5-year survival rate for children and adolescents with acute lymphoblastic leukemia (ALL) has improved to more than 90% in high-income countries. ...For immunotherapy, the approval of antibody-based therapy (with blinatumomab in 2014 and inotuzumab …
The 5-year survival rate for children and adolescents with acute lymphoblastic leukemia (ALL) has improved to more than …
Treatment of Childhood Acute Lymphoblastic Leukemia: Prognostic Factors and Clinical Advances.
Vrooman LM, Silverman LB. Vrooman LM, et al. Curr Hematol Malig Rep. 2016 Oct;11(5):385-94. doi: 10.1007/s11899-016-0337-y. Curr Hematol Malig Rep. 2016. PMID: 27502091 Review.
While the majority of children and adolescents with newly diagnosed childhood acute lymphoblastic leukemia (ALL) will be cured, as many as 20 % of patients will experience relapse. On current treatment regimens, the intensity of upfront treatment
While the majority of children and adolescents with newly diagnosed childhood acute lymphoblastic leukemia (ALL) will b …
Lymphoblastic lymphoma: an updated review on biology, diagnosis, and treatment.
Bassan R, Maino E, Cortelazzo S. Bassan R, et al. Eur J Haematol. 2016 May;96(5):447-60. doi: 10.1111/ejh.12722. Epub 2016 Jan 24. Eur J Haematol. 2016. PMID: 26679753 Review.
Lymphoblastic lymphoma is a rare aggressive neoplasm of T-/B-precursors resembling acute lymphoblastic leukemia, with no or limited bone marrow involvement (<25%), that develops more frequently in children and young adults and is typically ch
Lymphoblastic lymphoma is a rare aggressive neoplasm of T-/B-precursors resembling acute lymphoblastic leukem
New targeted therapies for relapsed pediatric acute lymphoblastic leukemia.
Pierro J, Hogan LE, Bhatla T, Carroll WL. Pierro J, et al. Expert Rev Anticancer Ther. 2017 Aug;17(8):725-736. doi: 10.1080/14737140.2017.1347507. Epub 2017 Jul 5. Expert Rev Anticancer Ther. 2017. PMID: 28649891 Free PMC article. Review.
The improvement in outcomes for children with acute lymphoblastic leukemia (ALL) is one of the greatest success stories of modern oncology however the prognosis for patients who relapse remains dismal. Recent discoveries by high resolution genomic technologie …
The improvement in outcomes for children with acute lymphoblastic leukemia (ALL) is one of the greatest success stories …
Genomics and pharmacogenomics of pediatric acute lymphoblastic leukemia.
Wu C, Li W. Wu C, et al. Crit Rev Oncol Hematol. 2018 Jun;126:100-111. doi: 10.1016/j.critrevonc.2018.04.002. Epub 2018 Apr 10. Crit Rev Oncol Hematol. 2018. PMID: 29759551 Review.
Acute lymphoblastic leukaemia (ALL) is a prevalent form of pediatric cancer that accounts for 70-80% of all leukemias. ...The other ALLs include Early T-cell precursor ALL, Philadelphia chromosome-like ALL, Down syndrome-associated ALL and Relap
Acute lymphoblastic leukaemia (ALL) is a prevalent form of pediatric cancer that accounts for 70-80% of all leukemias.
Next-Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic Leukemia.
Heikamp EB, Pui CH. Heikamp EB, et al. J Pediatr. 2018 Dec;203:14-24.e2. doi: 10.1016/j.jpeds.2018.07.039. Epub 2018 Sep 10. J Pediatr. 2018. PMID: 30213460 Free PMC article. Review. No abstract available.
Epigenetics in pediatric acute lymphoblastic leukemia.
Nordlund J, Syvänen AC. Nordlund J, et al. Semin Cancer Biol. 2018 Aug;51:129-138. doi: 10.1016/j.semcancer.2017.09.001. Epub 2017 Sep 5. Semin Cancer Biol. 2018. PMID: 28887175 Free article. Review.
Acute lymphoblastic leukemia (ALL) is the most common malignancy in children. ...Recent technical advances and decreasing costs of methods for high-throughput DNA sequencing and SNP genotyping have stimulated systematic studies of the epigenetic changes
Acute lymphoblastic leukemia (ALL) is the most common malignancy in children. ...Recent technical advances and decreasi
New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia.
Jabbour E, O'Brien S, Konopleva M, Kantarjian H. Jabbour E, et al. Cancer. 2015 Aug 1;121(15):2517-28. doi: 10.1002/cncr.29383. Epub 2015 Apr 17. Cancer. 2015. PMID: 25891003 Free article. Review.
Significant advances have been made in the last decade toward a better understanding of the disease pathogenesis and the development of novel therapies that target specific subsets of adult acute lymphoblastic leukemia (ALL). Risk-adapted strategies are trans …
Significant advances have been made in the last decade toward a better understanding of the disease pathogenesis and the development of nove …
31,699 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback